Stahist AD Liquid

Drug Labeling and Warnings

Drug Details [pdf]

STAHIST AD- chlorcyclizine hydrochloride and pseudoephedrine hydrochloride liquid 
MAGNA Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Stahist AD Liquid

Drug Facts

Active Ingredients
(in each 5 mL teaspoonful) 		Purpose
Chlorcyclizine HCl 25 mgAntihistamine
Pseudoephedrine HCl 60 mgNasal Decongestant

Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • nasal congestion
  • reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

  • If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes melitus
  • difficulty in urination due to enlargement of the prostate gland

Ask a doctor before use if you are taking sedatives or tranquilizers

When using this product

  • excitability may occur, especially in children
  • may cause drowsiness
  • alcohol, sedatives and tranquilizers may increase drowsiness
  • avoid alcoholic beverages
  • use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

  • nervousness, dizziness or sleeplessness occur
  • symptoms persist for more than 1 week, tend to recur, or are accompanied by a fever, rash or persisitent headache; these could be signs of a serious condition
  • new symptoms occur

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

Do not exceed recommended dosage.

Adults and children 12 years of age and over:1 teaspoon every 6-8 hours, not to exceed 3 teaspoonfuls in 24 hours, or as directed by a doctor
Children 6 to under 12 years of age:½ teaspoonful every 6-8 hours, not to exceed 1½ teaspoonfuls in 24 hours, or as directed by a doctor
Children under 6 years of ageConsult a doctor

Inactive ingredients

Citric Acid, Grape Flavor, Methyl Paraben, Potassium Citrate, Potassium sorbate, Propyl Paraben, Propylene Glycocl, Purified Water, Sorbitol Solution 70%, Sucralose

Questions or Comments?

Call 1-888-206-5525

Rev. 02/12

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton

NDC: 58407-624-04

Stahist AD
LIQUID

Antihistamine Nasal Decongestant

GRAPE FLAVOR!

SUGAR-FREE

ALCOHOL-FREE

GLUTEN-FREE

Each teaspoonful (5 mL) for oral
administration contains:
Chlorcyclizine HCl         25 mg
Pseudoephedrine HCl   60 mg

Manufactured for:
MAGNA
Pharmaceuticals, Inc.
Louisville, KY 40299

Net Contents: 4 oz (118 mL)

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton
STAHIST AD 
chlorcyclizine hydrochloride and pseudoephedrine hydrochloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 58407-624
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORCYCLIZINE HYDROCHLORIDE (UNII: NPB7A7874U) (CHLORCYCLIZINE - UNII:M26C4IP44P) CHLORCYCLIZINE HYDROCHLORIDE25 mg  in 5 mL
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POTASSIUM CITRATE (UNII: EE90ONI6FF)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SORBITOL (UNII: 506T60A25R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
Color    Score    
ShapeSize
FlavorGRAPEImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 58407-624-04118 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/01/201609/01/2019
2NDC: 58407-624-1010 mL in 1 BOTTLE; Type 0: Not a Combination Product04/01/201209/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34104/01/201209/01/2019
Labeler - MAGNA Pharmaceuticals, Inc. (620988360)

Revised: 9/2019
Document Id: 91bba3cc-ba6a-7163-e053-2a95a90a42e8
Set id: 4e1bd76c-3fd8-4372-907f-6b799d67cfbb
Version: 2
Effective Time: 20190904